Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 820-260-6 | CAS number: 93603-76-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation, other
- Remarks:
- Qsar in silico prediction
- Type of information:
- (Q)SAR
- Adequacy of study:
- supporting study
- Study period:
- 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
- Justification for type of information:
- 1. SOFTWARE:
DEREK NEXUS
2. MODEL (INCL. VERSION NUMBER)
DEREK NEXUS Lhasa edition
3. SMILES OR OTHER INDENTIFIERS USED AS INPUT FOR THE MODEL
CAS NUMBER: (5R, 6S)-allyl-6-((R)-1-(tert-butyldimethylsilyloxy)ethyl)-7-oxo-3-(propylthio)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
4.SCIENTIFIC VALIDITY OF THE QSAR MODEL
This above mentioned tool was selected according to the OECD Guidance Documents on the VAlidation of (Q)SAR models:
-Document on the Validation of (Quantitative) Structure Acitivity Relationship models. OECD Series on testing and Assessment Nà69 ENV/JM/MONO (2007)2.
- Enoch SJ, Madden J.C, Cronin M.T.(2008),Identification of mechanism of toxic action for skin sensitisation using a SMARTS pattern based approach, SAR QSAR Envir Res., 19(5-6):555-78
5.APPLICABILITY DOMAIN
-DEREK NEXUS: the prediction is generated by applying expert knowledge rules in toxicology
6. ADEQUACY OF THE RESULT
Derek Nexus: Skin sensitisastion is plausible
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Series on testing and assessment n.69
- Version / remarks:
- ENV/JM/MONO(2007)2
- Deviations:
- not specified
Test material
- Reference substance name:
- (5R,6S)-allyl 6-((R)-1-(tert-butyldimethylsilyloxy)ethyl)-7-oxo-3-(propylthio)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
- EC Number:
- 820-260-6
- Cas Number:
- 93603-76-0
- Molecular formula:
- C20H33NO4S2Si
- IUPAC Name:
- (5R,6S)-allyl 6-((R)-1-(tert-butyldimethylsilyloxy)ethyl)-7-oxo-3-(propylthio)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
Constituent 1
Results and discussion
In vitro / in chemico
Results
- Parameter:
- other: QSAR prediction is not an in vitro study
- Remarks on result:
- other: QSAR prediction skin sensitiser
In vivo (non-LLNA)
Results
- Reading:
- other: QSAR it is not an in vivo study
- Remarks on result:
- other: QSAR prediction skin sensitiser
In vivo (LLNA)
Results
- Parameter:
- other: QSAR it is not an in vivo study
- Remarks on result:
- other: QSAR prediction Skin sensitiser
Any other information on results incl. tables
This study was designated to generate estimated "in silico" data to be used for the hazard assessment of the substance.
the table below shows the result obtained:
ENDPOINT | DEREK NEXUS PREDICTION |
SKIN SENSITISATION | PLAUSIBLE |
Skin sensitisation: murine local lymph node assay (LLNA), guinea pig maximisation test (GPMT), human maximisation patch test Potential mechanism: Hapten acting as an electrophilic acylating agent [Aptula and Roberts] Fused beta-lactam molecules based on the penicillin (II) and cephalosporin (III) scaffold have demonstrated sensitisation in the LLNA, GPMT and human maximisation patch test. The most studied compound is penicillin G (benzylpenicillin) which has displayed activity in the LLNA [Ashby et al], GPMT [Kristofferson et al] and human maximisation patch test [Kligman].
Two additional penicillins [Kristofferson et al] and seven cephalosporin-based antibiotics [Hattori et al] have also shown activity in the GPMT, examples include cephalothin and flomoxef. In support of toxicophore (I) unfused beta-propiolactone is classified as a strong sensitiser in the LLNA [Ashby et al]. In exposed human populations, sensitisation to penicillin was reported in 21 out of 333 nurses [Rudzki et al 1989a] and 8 out of 107 pharmaceutical workers [Rudzki et al 1989b] with occupational dermatitis. In their role as antibiotics, beta-lactams are electrophilic acylating agents that undergo ring-opening [Page and Laws] and are expected to promote skin sensitisation through the formation of adducts with skin proteins through a similar mechanism. Whilst fused beta-lactam systems (II, III) are inherently reactive due to distorted amide bond geometries, unfused monolactams possess comparable hydrolysis rates to acyclic amides [Washkuhn and Robinson]. Conversely, beta-lactones (I) are highly reactive acylating agents [Perez-Prior et al]. The scope of this alert has been defined to include fused lactam and unfused lactone molecules with positive LLNA, GPMT or human patch test results. beta-Lactam containing pharmaceuticals conforming to toxicophores II and III have been designed to be efficient acylating agents. Features that promote reactivity include an electron withdrawing substituent positioned at C3 [Boyd et al] or a leaving group at 3' in cephalosporins [Boyd, Perez-Inestrosa et al]. Sulphoxides, sulphones or ethers attached to C4 also promote reactivity [Mulchande et al] with tazobactam reported to produce a moderate sensitising response in the LLNA [ECHA 2008]. Additionally clavulanic acid was responsible for a case of occupational contact dermatitis in one subject [Kim et al] but did not produce a positive response in the LLNA up to 50%, despite exhibiting dose-related responses [ECHA 2013]. Thioxocephalosporin [Tsang et al] demonstrated similar reactivity to cephalosporin Derek Nexus Prediction Report and therefore thio-analogues of penicillins and cephalosporins are included in the alert. Unfused beta-lactams are excluded from this alert based on their lack of reactivity, but unfused betalactones (I) [Perez-Prior et al] and beta-thioxolactones are inherently reactive and therefore are included with the scope of this alert.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- skin sensitisation:
Prediction : plausible - Executive summary:
The skin sensitisation of the target compound was predicted employing an in silico approach: the decision rule system provided by Derek Nexus.
The predictor was employed in order to apply a weight of evidence approach. In the case of the target PF-598 Derek Nexus predicted the skin sensistisation as plausible.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.